Subscribe
The latest psychology and neuroscience discoveries.
My Account
  • Mental Health
  • Social Psychology
  • Cognitive Science
  • Psychopharmacology
  • Neuroscience
  • About
No Result
View All Result
PsyPost
PsyPost
No Result
View All Result
Home Exclusive Psychopharmacology Psychedelic Drugs Psilocybin

Man amputates penis with an axe after consuming psilocybin mushrooms

by Eric W. Dolan
September 29, 2024
in Psilocybin
[Adobe Stock]

[Adobe Stock]

Share on TwitterShare on Facebook

In an unprecedented case report, doctors in Austria have documented the first known instance of psilocybin-induced penile amputation. After consuming a large quantity of magic mushrooms, a 37-year-old man suffering from depression and alcohol abuse severed his penis with an axe. Fortunately, doctors were able to reattach part of the amputated organ. The unique case is detailed in the Mega Journal of Surgery.

Psilocybin is a naturally occurring psychedelic compound found in certain species of mushrooms, often referred to as “magic mushrooms.” When ingested, the compound is broken down in the body to produce psilocin, a substance that affects serotonin receptors in the brain. This can lead to a variety of mind-altering experiences, including hallucinations, changes in perception of time, and intense emotional shifts. The use of psilocybin has a long history, dating back to ancient cultures that used it for religious or spiritual purposes.

Today, psilocybin is gaining attention in medical research due to its potential therapeutic benefits. Scientists are investigating its use in treating conditions like depression, anxiety, and post-traumatic stress disorder. In particular, studies have shown promising results for psilocybin’s ability to alleviate symptoms in people with major depressive disorder, even when other treatments have failed.

In addition to its therapeutic potential, psilocybin is of interest to neuroscientists for what it reveals about the brain’s inner workings. By studying how psilocybin disrupts and alters normal brain function, researchers can gain insights into how the brain produces consciousness, processes emotions, and constructs a sense of self. These findings have the potential to improve our understanding of various mental health conditions and open new pathways for treatment.

However, while psilocybin has shown promise in clinical settings, its use outside of these controlled environments can lead to dangerous outcomes. The case described in Austria is a stark reminder that, in certain circumstances, psilocybin can provoke extreme psychological responses, particularly when taken in high doses or by individuals with a history of mental health issues.

The case report published by doctors at Hospital Feldkirch in Austria outlines the shocking details of a 37-year-old man who consumed a large dose of psilocybin and, during a severe psychotic episode, amputated his penis using an axe. The man, who had a history of depression and alcohol abuse, ingested four or five dried psilocybin mushrooms while staying alone in a secluded vacation home.

Not long after consuming the mushrooms, the man began to experience a terrifying hallucination or delusion, which led him to take an axe and sever his penis into multiple pieces. The details of the event are unclear to the patient, as he did not fully remember what had occurred.

The man reportedly tied a piece of cloth around his genital area to control the bleeding and placed the severed parts of his penis in a jar filled with snow. He then left the house, bleeding profusely, in search of help. A passerby found him in a confused state and called for emergency services. The man was transported to a nearby village and later to a hospital, arriving approximately five hours after the amputation.

Upon arrival, the patient was in a critical condition, having lost a significant amount of blood. He was immediately taken into surgery, where doctors worked to stabilize him and control the bleeding. His penis was contaminated with soil and snow, and parts of the organ were severely damaged. Surgeons were able to save the glans (the tip of the penis) and about two centimeters of the penile shaft, but the other sections were too damaged to be repaired.

Remarkably, the replantation was successful, despite the significant challenges posed by the extent of the injury and contamination. Despite initial difficulties, the patient’s condition improved after the surgery, although he continued to suffer from severe psychotic symptoms, including auditory hallucinations and religious delusions. He was placed under psychiatric care, and his treatment included antipsychotic medications to help control the hallucinations. His mental state gradually stabilized, and after a week, he was moved back to the urology department to continue his recovery.

In the weeks following the surgery, the patient experienced some complications. Superficial necrosis (death of skin tissue) developed on the glans of his penis, likely due to the loss of blood flow during the period of ischemia, but this healed over time. Remarkably, the patient was able to regain some erectile function within three months of the surgery, though the overall length of his penis was significantly reduced due to the damage. At his last follow-up visit, he was able to urinate normally while seated, though a minor complication called hypospadias developed, where the urethral opening is located further down the shaft than normal.

While this case is the first documented instance of psilocybin-induced self-amputation, it brings attention to a broader phenomenon of self-mutilation during psychotic episodes, particularly among individuals with underlying mental health conditions. Known as Klingsor syndrome, these rare but extreme events often involve self-inflicted injury to the genitals and can be associated with a range of psychiatric conditions, from schizophrenia to substance-induced psychosis.

Case reports are typically used by doctors and researchers to document unusual or rare medical events. They offer valuable real-world examples of how certain drugs, treatments, or conditions can manifest in unique circumstances. However, because case reports usually focus on a single patient, they do not provide the kind of broad, statistically significant data that is needed to establish definitive conclusions about a drug or condition.

In other words, while this case demonstrates that psilocybin can, in rare instances, lead to severe psychotic episodes and self-harm, it does not mean that this outcome is common or likely to happen in most people who use psilocybin. In fact, the majority of research on psilocybin has shown that the drug is relatively safe when used in controlled environments with professional supervision.

Despite their limitations, case reports play a critical role in advancing medical knowledge. They help doctors identify rare side effects, potential risks, and best practices for managing complex cases. In the case of psilocybin, reports like this one could influence future guidelines for its therapeutic use and highlight the need for careful screening of patients before administering psychedelic treatments.

The case report, “Penile Replantation after Self-Amputation Following Psilocybin-Induced Drug Psychosis,” was authored by Andreas P. Berger and and Alfred Hobisch.

RELATED

Analysis of 45 serial killers sheds new light on the dark psychology of sexually motivated murderers
Neuroimaging

Scientists pinpoint cellular mechanism behind psilocin’s effects on brain activity

November 19, 2025
Psychedelic mushrooms and quiet quitting: Psilocybin use tied to working fewer overtime hours
Depression

Psilocybin therapy linked to lasting depression remission five years later

October 27, 2025
New study highlights psilocybin’s promise for major depressive disorder treatment
Psilocybin

Psilocybin therapy linked to reduced suicidal thoughts in people with psychiatric disorders

October 9, 2025
Psilocybin-assisted group therapy may help reduce depression and burnout among healthcare workers
Psilocybin

Psilocybin-assisted group therapy may help reduce depression and burnout among healthcare workers

October 4, 2025
Extraverts show faster, stronger, and more patterned emotional reactions
Depression

Single dose of psilocybin linked to lasting symptom relief in treatment-resistant depression

September 8, 2025
Neuroscientists just rewrote our understanding of psychedelics with a groundbreaking receptor-mapping study
Ayahuasca

Neuroscientists just rewrote our understanding of psychedelics with a groundbreaking receptor-mapping study

September 1, 2025
Surprising link found between aesthetic chills and political extremism
Anxiety

Single dose of psilocybin provides lasting relief from depression and anxiety in cancer patients

August 27, 2025
Scientists uncover biological pathway that could revolutionize anxiety treatment
MDMA

Psilocybin and MDMA may reset fear-related brain-immune signaling, scientists find

August 25, 2025

PsyPost Merch

STAY CONNECTED

LATEST

New research highlights the role of family background and attachment in shaping infidelity intentions

Large-scale trial finds four-day workweek improves employee well-being and physical health

Family-oriented women rely more on social cues when judging potential partners

Study identifies creativity and resilience as positive aspects of ADHD diagnosis

Pro-inflammatory diets linked to accelerated brain aging in older adults

Evidence suggests sex differences in the brain are ancient and evolutionary

New research reveals the cognitive hurdles created by our number systems

Lonely children have an increased risk of dementia and cognitive decline in adulthood, study finds

RSS Psychology of Selling

  • The hidden power of sequence in business communication
  • What so-called “nightmare traits” can tell us about who gets promoted at work
  • What 5,000 tweets reveal about the reality of Black Friday deals
  • A bad mood might not hurt your work productivity as much as you think
  • The surprising power of purchase preconditions in retail
         
       
  • Contact us
  • Privacy policy
  • Terms and Conditions
[Do not sell my information]

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Subscribe
  • My Account
  • Cognitive Science Research
  • Mental Health Research
  • Social Psychology Research
  • Drug Research
  • Relationship Research
  • About PsyPost
  • Contact
  • Privacy Policy